Gerresheimer divests two businesses worth €1.5B; Resilience, Lilly boost injectable pen capacitynews2026-07-30T13:30:04+00:00July 30th, 2026|Endpoints News|
Teva is confident it has time to brace for tariffs on non-US genericsnews2026-07-29T17:27:21+00:00July 29th, 2026|Endpoints News|
The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO saysnews2026-07-27T18:30:58+00:00July 27th, 2026|Endpoints News|
FDA to end pilot aimed at preventing production issuesnews2026-07-23T18:24:20+00:00July 23rd, 2026|Endpoints News|
Sartorius reduces revenue by €26M to refund Trump tariffs to customersnews2026-07-23T16:00:28+00:00July 23rd, 2026|Endpoints News|
Repligen’s $1.5B buy for BioLife; BeOne’s $300M US expansion news2026-07-23T13:01:21+00:00July 23rd, 2026|Endpoints News|
Trump pledges new tariffs on generic drugs not made in the USnews2026-07-22T00:38:47+00:00July 22nd, 2026|Endpoints News|
House lawmakers back trade probe of China biotech, sequencingnews2026-07-20T17:06:10+00:00July 20th, 2026|Endpoints News|
Samsung Bio to step into peptides in $1.8B buy for PolyPeptidenews2026-07-20T16:18:29+00:00July 20th, 2026|Endpoints News|
US drug shortages rise for third straight quarter, hurt by lone suppliersnews2026-07-16T14:13:57+00:00July 16th, 2026|Endpoints News|
